HOME >> BIOLOGY >> NEWS
When predators attack (each other)

NEW YORK (MAY 5, 2002) -- Lesson one: don't steal a bear's dinner. Last week, a wolverine - a ferocious member of the weasel family able to kill a caribou - learned this the hard way, according to a team of researchers from the New York-based Wildlife Conservation Society (WCS).

Scientists Kristine and Bob Inman, while tracking the wolverine as part of a WCS study of these rare carnivores, discovered that the animal's radio collar began emitting a "mortality signal," indicating it hadn't moved in several hours. They later found the wolverine's carcass, showing clear evidence that it had been killed by a bear. Nearby, they discovered the carcass of an elk, along with additional evidence that the wolverine had attempted to drag it away from the bear, thus instigating the fatal encounter.

"This incident, where a wolverine decided to battle it out head-on with another carnivore ten times his size, substantiates the species' ferocious and intrepid reputation. The center of the conflict, an elk, may have been a "winter-kill," frozen in the snow until discovered by the bear emerging from its winter hibernation," said Kristine Inman.

The wolverine was one of a number of individuals WCS researchers have been tracking in the Greater Yellowstone Ecosystem for the past two winters. Researchers are investigating threats to wolverine populations to provide state and federal agencies with data about survival and reproductive rates, travel corridors and habitat use. The degree to which increasing development and back-country recreational use in mountainous areas threatens wolverine populations is unknown. Understanding threats to this rare and elusive animal is essential to its conservation.

Last month, another team of WCS researchers discovered another carnivore oddity, when they learned that a mountain lion they were tracking in Yellowstone National Park had been attacked and killed by a pack of wolves.


'"/>

Contact: Stephen Sautner
ssautner@wcs.org
718-220-3682
Wildlife Conservation Society
5-May-2003


Page: 1

Related biology news :

1. International science team tracks ocean predators around the globe
2. Rapid evolution helps hunted outwit their predators
3. On Californias Channel Islands, native predators became prey when feral pigs rearranged the food web
4. Brittlestars use crystal lenses to spot approaching predators unique visual system is the first of its kind to be discovered in animals inhabiting the earth today
5. All specialized insect predators not suitable for biological control
6. Beetle uses fecal defense against predators
7. New Science study revisits the debate over bird parents, predators, and family planning
8. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
9. Smart gene therapy protects against damage from heart attack
10. Two-pronged attack targeting EGF receptor hinders cancer cell growth
11. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: When predators attack each other

(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ... "Facial Recognition Market by Solution, by Software, by ... 2020" report to their offering. ... technology become more efficient and cost effective. This ... investment from the commercial sector. The development of ...
(Date:5/28/2015)... 2015 Industry analyst firm n-tech Research ... titled "Markets for Self-Healing Materials: 2015-2022." According to the ... vascular systems, biomaterials, relevant shape memory materials and ... billion by 2020. The report is ... smart materials. Other recent n-tech reports have included studies ...
(Date:5/27/2015)... 2015   Codonics (codonics.com), a ... image documentation solutions and Omnicell  (omnicell.com), ... solutions, is pleased to announce their state ... Label System® (SLS), an award-winning FDA class ... Omnicell Anesthesia Workstation, helps prevent medication errors, ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
(Date:5/30/2015)... May 30, 2015 CTI BioPharma Corp. (CTI ... business (NYSE: BAX ) today announced data from ... pacritinib for the treatment of myelofibrosis – in a ... of the American Society of Clinical Oncology (ASCO), May ... Pacritinib is an investigational oral multikinase inhibitor with ...
(Date:5/30/2015)... CHICAGO and RARITAN, N.J. ... the international, multi-center, open-label, two-part, single-arm Phase 2 ... – an investigational, human anti-CD38 monoclonal antibody – ... percent (95% CI, 20.8-38.9), as assessed by an ... multiple myeloma. The ORR was consistent among the ...
(Date:5/30/2015)... Texas , May 30, 2015  Caris ... from a study in which researchers identified biomarker ... metachronous paired glioma tumors, indicating changes in response ... observing 19 patients was a subset of a ... molecular heterogeneity of the cancer. These data utilizing ...
(Date:5/29/2015)... CHAPEL HILL, N.C. , May 29, 2015 ... the medical affairs function into roles involving clinical ... As its responsibilities have grown, Medical Affairs ... the function as a global group. And while ... sometimes find it challenging to identify strong performance ...
Breaking Biology Technology:Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 2Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 4Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 5Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 6Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 7Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 8Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 9Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 10Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 2Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 3Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 4Creating an Effective Pharmaceutical Medical Affairs Group with Global Capabilities 2
Cached News: